Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ANTENGENE THERAPEUTICS LIMITED”

2 pharma patents match "ANTENGENE THERAPEUTICS LIMITED" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "ANTENGENE THERAPEUTICS LIMITED" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “ANTENGENE THERAPEUTICS LIMITED” · 30,257 patents in full index Clear search

  1. US 12421273

    Ectonucleotidase inhibitors and methods of use thereof

    ANTENGENE THERAPEUTICS LIMITED · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 11858957

    Ectonucleotidase inhibitors and methods of use thereof

    ANTENGENE THERAPEUTICS LIMITED · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted